Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Johanna Nagel"'
Publikováno v:
JMIR mHealth and uHealth, Vol 12, p e50616 (2024)
BackgroundMusculoskeletal diseases affect 1.71 billion people worldwide, impose a high biopsychosocial burden on patients, and are associated with high economic costs. The use of digital health interventions is a promising cost-saving approach for th
Externí odkaz:
https://doaj.org/article/e87c6f9b644b44c59c5e2743248c070d
Background: To examine rates of serious pneumococcal infections up to 10 years after vaccination with 7-valent conjugated pneumococcal vaccine (PCV7) in patients with arthritis compared to non-vaccinated arthritis patients.Methods: In total, 595 adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ba589485219d6fac9a997d783a374a
https://doi.org/10.21203/rs.3.rs-1145857/v1
https://doi.org/10.21203/rs.3.rs-1145857/v1
Autor:
Per Nived, Johanna Nagel, Pierre Geborek, Tore Saxne, Thomas Mandl, Meliha C Kapetanovic, Lillemor Skattum
Publikováno v:
Poster Presentations.
Objectives To investigate if antibody response and functionality of antibodies following immunization with 13-valent pneumococcal conjugate vaccine (PCV13) is impaired in patients with rheumatoid arthritis (RA) and primary Sjogrens syndrome (pSS) wit
Autor:
Søren Jacobsen, Johanna Nagel, C Svaerke Joergensen, Andreas Jönsen, Meliha C Kapetanovic, Anders A. Bengtsson, J-Å Nilsson, Tore Saxne, Lillemor Skattum, Pierre Geborek
Publikováno v:
Lupus. 26(10)
Background/purpose The objective of this study was to explore the impact of systemic lupus erythematosus and belimumab given in addition to standard of care therapy on 13-valent conjugated pneumococcal vaccine (PCV13) response. Methods Forty-seven sy
Autor:
Meliha C Kapetanovic, Tore Saxne, Lillemor Skattum, Per Nived, Göran Jönsson, Pierre Geborek, Johanna Nagel
Publikováno v:
Vaccine. 35(29)
Aim To study the effect of standard of care therapy on antibody response and functionality following immunization with 13-valent pneumococcal conjugate vaccine (PCV13) in patients with primary systemic vasculitis compared to healthy controls. Methods
Publikováno v:
Vaccine; 35(6), pp 903-908 (2017)
Background: Treatment with methotrexate (MTX) in patients with rheumatoid arthritis (RA) leads to decreased total immunoglobulin (Ig) levels and impairs vaccine-specific IgG antibody levels following pneumococcal vaccination. The mechanisms by which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f24372094b659c06e92776d8cdec46ee
https://lup.lub.lu.se/record/3e89cf87-731f-44db-8ddc-8ae4f36932c4
https://lup.lub.lu.se/record/3e89cf87-731f-44db-8ddc-8ae4f36932c4
Autor:
Göran Jönsson, Ingemar F Petersson, Martin Englund, Jan-Åke Nilsson, Tore Saxne, Meliha C Kapetanovic, Johanna Nagel, Pierre Geborek
Publikováno v:
Scandinavian journal of rheumatology. 44(4)
To examine the risk of putative pneumococcal infections in adult arthritis patients on different anti-rheumatic drugs immunized with heptavalent pneumococcal conjugate vaccine (Prevenar 7; PCV7) and non-vaccinated individually matched arthritis patie
Autor:
Per Nived, Pierre Geborek, Lillemor Skattum, Johanna Nagel, Göran Jönsson, Tore Saxne, Meliha C Kapetanovic
Publikováno v:
Annals of the Rheumatic Diseases. 75:574.2-574
Objectives To study the effect of standard of care therapy on antibody (Ab) response and functionality of Abs following pneumococcal vaccination using 13-valent conjugate vaccine (PCV13) in patients with systemic vasculitis compared to healthy contro
Autor:
Pierre Geborek, Göran Jönsson, Johanna Nagel, Martin Englund, M. Crnkic Kapetanovic, Jan-Åke Nilsson, Tore Saxne, Ingemar F Petersson
Publikováno v:
Annals of the Rheumatic Diseases. 73:459.3-460
Background Antibody response after vaccination is a surrogate measure of vaccine efficacy. Studies exploring the association between post-vaccination antibody levels and protection against infections after immunization with pneumococcal conjugate vac